Pfizer Inc’s chief executive on Thursday said recent proposals by Democratic presidential candidate Hillary Clinton to curb “unjustified” U.S. drug prices would dampen investment in innovative new drugs and ultimately hurt consumers. “(They) would be very negative for innovation,” Ian Read said in webcast from the annual Wells Fargo healthcare ... Read More »

NEW YORK: US pharmaceutical giant Pfizer said Wednesday it was abandoning plans for a $160 billion merger with Allergan, citing new US rules cracking down on tie ups aimed at saving on taxes. The deal with the Irish-based firm would have created the world’s largest pharmaceutical company. Pfizer said in ... Read More »